Remyelination therapies: a new direction and challenge in multiple sclerosis | Nature Reviews Drug Discovery
The antibody rHIgM22 facilitates hippocampal remyelination and ameliorates memory deficits in the cuprizone mouse model of demyelination - ScienceDirect
A double-blind, placebo-controlled, single-ascending-dose intravenous infusion study of rHIgM22 in subjects with multiple sclerosis immediately following a relapse - Benjamin M. Greenberg, James D. Bowen, Enrique Alvarez, Moses Rodriguez, Anthony O ...
The antibody rHIgM22 facilitates hippocampal remyelination and ameliorates memory deficits in the cuprizone mouse model of demyelination - ScienceDirect
rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination | Semantic Scholar
Frontiers | Novel Molecular Leads for the Prevention of Damage and the Promotion of Repair in Neuroimmunological Disease
Pushing Forward: Remyelination as the New Frontier in CNS Diseases: Trends in Neurosciences
Human IgM antibody rHIgM22 promotes phagocytic clearance of myelin debris by microglia | Scientific Reports
The antibody rHIgM22 facilitates hippocampal remyelination and ameliorates memory deficits in the cuprizone mouse model of demyelination - ScienceDirect
A double-blind, placebo-controlled, single-ascending-dose intravenous infusion study of rHIgM22 in subjects with multiple sclero
Human IgM antibody rHIgM22 promotes phagocytic clearance of myelin debris by microglia | Scientific Reports
PDF) A double-blind, placebo-controlled, single ascending-dose study of remyelinating antibody rHIgM22 in people with multiple sclerosis
rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination | Semantic Scholar
Human IgM antibody rHIgM22 promotes phagocytic clearance of myelin debris by microglia | Scientific Reports
Structure, Function, and Therapeutic Use of IgM Antibodies
Dr. Brandon Beaber on Twitter: "A diagram looking at potential remyelinating therapies for MS from an excellent article in Elsevier. Authors: @Calabre04804429 @bannon_riley @marjangh20 https://t.co/vonWPAXOwH https://t.co/scbkmxyN4v" / Twitter
Acorda Announces Phase 1 Results for Remyelinating Antibody in Multiple Sclerosis
Acorda Announces Phase 1 Results for Remyelinating Antibody in Multiple Sclerosis
Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease | SpringerLink
Human IgM antibody rHIgM22 promotes phagocytic clearance of myelin debris by microglia | Scientific Reports
Human IgM antibody rHIgM22 promotes phagocytic clearance of myelin debris by microglia | Scientific Reports
Stimulation of primary microglia with rHIgM22 promotes myelin... | Download Scientific Diagram
Human IgM antibody rHIgM22 promotes phagocytic clearance of myelin debris by microglia | Scientific Reports
The antibody rHIgM22 facilitates hippocampal remyelination and ameliorates memory deficits in the cuprizone mouse model of demyelination - ScienceDirect
